Price
$121.99+9.88%Social Signal Score
Analyst Ratings
27 analysts52-week range
- Last close
- $121.99
- Off 52w high
- -4.1%
- 200-day average
- $106.86
- vs 200-day
- +14.2%
Revenue
$1.60B+75.15%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Mark J. Tarr
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 29,699
- Beta
- 0.61
- Country
- US
- Piotroski score
- 8 / 9 (Strong)
- Altman Z-score
- 3.51
Financials
Revenue
$1.60B+75.2%Net Income
$153.90M+149.4%EBITDA
$384.80M+86.5%Free Cash Flow
$62.30M-53.1%EPS (diluted)
$1.54+140.6%Shares Outstanding (diluted)
100.00M+0.6%Operating Expenses
$62.60MCash & Debt
$107.70MReturn of Capital
$93.10MRevenue by Segment (annual)
$5.94BDividend per Share
$0.21Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.94B | $566.20M | $5.62 |
| 2024 | $5.37B | $455.70M | $4.53 |
| 2023 | $4.80B | $352.00M | $3.54 |
| 2022 | $4.35B | $271.00M | $2.72 |
| 2021 | $4.01B | $412.20M | $4.15 |
| 2020 | $3.57B | $284.20M | $2.87 |
| 2019 | $4.61B | $358.70M | $3.65 |
| 2018 | $4.28B | $292.30M | $2.99 |
| 2017 | $3.91B | $271.10M | $2.73 |
| 2016 | $3.64B | $247.60M | $2.77 |
| 2015 | $3.12B | $183.10M | $2.02 |
| 2014 | $2.37B | $222.00M | $2.46 |
| 2013 | $2.25B | $323.60M | $2.58 |
| 2012 | $2.13B | $185.00M | $1.67 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from EHC's reported EPS growth of 9.8% a year over 13 years.
- EPS in 5 years
- $8.99
- Implied price
- $170.83
- Return from $121.49
- 7.1% a year
To earn 15.0% a year on these assumptions you'd need to buy at $84.93 — -30.1% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 13 | 16 | 19 | 22 | 25 |
|---|---|---|---|---|---|
| -0.2% | -9.8% | -6.0% | -2.7% | 0.2% | 2.8% |
| 4.8% | -5.3% | -1.3% | 2.2% | 5.2% | 7.9% |
| 9.8% | -0.8% | 3.4% | 7.1% | 10.2% | 13.1% |
| 14.8% | 3.7% | 8.1% | 11.9% | 15.3% | 18.2% |
| 19.8% | 8.3% | 12.9% | 16.8% | 20.3% | 23.4% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
70+40.00%Social Signal Score
Mentions (27)
- Newszacks.com·22h ago·Positive
Here's Why Encompass Health (EHC) is a Strong Growth Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - Newsprnewswire.com·4d ago·Neutral
Encompass Health announces date of 2026 third-quarter earnings call BIRMINGHAM, Ala., Oct. 1, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its third quarter ended Sept.
View source ↗ - Newszacks.com·10d ago·Neutral
Encompass Health Adds New Capacity With First Small-Format Hospital EHC is expanding near Houston with its first small-format rehab hospital and a 60-bed replacement facility in The Woodlands.
View source ↗ - News (RSS)investing·11d ago·Neutral
Encompass Health plans two hospitals in Montgomery County, Texas
View source ↗ - Newsprnewswire.com·11d ago·Neutral
Encompass Health expands in Montgomery County, Texas, with first small-format hospital, replacement hospital BIRMINGHAM, Ala., and CONROE, Texas, Sept.
View source ↗ - Newszacks.com·11d ago·Positive
Encompass Health (EHC) Upgraded to Buy: Here's Why Encompass Health (EHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
View source ↗ - Newszacks.com·17d ago·Positive
Here's Why Encompass Health (EHC) is a Strong Growth Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
View source ↗ - Newsprnewswire.com·20d ago·Neutral
Encompass Health Rehabilitation Hospital of Lower Providence now open in Pennsylvania BIRMINGHAM, Ala. and EAGLEVILLE, Pa.
View source ↗ - News (RSS)yahoo·29d ago·Neutral
Encompass Health (EHC): This Rehab Hospital Giant Just Raised Its Own Bar Again
View source ↗ - News (RSS)seekingalpha·38d ago·Positive
Encompass Health Is Healthy Enough To Justify A Bullish View
View source ↗ - Newsseekingalpha.com·38d ago·Positive
… Corporation is the largest U.S. inpatient rehabilitation hospital operator, showing robust top- and bottom-line growth with industry-leading balance sheet strength. EHC is executing a disciplined expansion strategy, targeting 6–10 new hospitals and 80–120 bed additions annually, supported by favorable US demographic trends. Despite trading at a premium to peers, EHC's valuation remains attractive given its growth, profitability, and declining net leverage ratio.
View source ↗ - Newszacks.com·41d ago·Neutral
How EHC's Capacity Expansion Fuels a Multi-Year Growth Runway Encompass Health's capacity expansion, new facilities and North Carolina pipeline could fuel 6-8% multi-year discharge growth.
View source ↗ - Newszacks.com·41d ago·Positive
Why Encompass Health (EHC) is a Top Momentum Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
View source ↗ - 4chan /biz/biz·42d ago·Neutral
Gemini's recommendation with my script Encompass Healthcare >mid cap >10% annual revenue growth >not levered >growing FCF >growing EPS >Doesn't print new shares >keeps reinvesting benefits into growing the business It is a as simple to ask a bot things that make a good business and you have a free stock screener. Just check the annual reports and stock price evolution to check for fishy stuff, but your free chatbot is a better financial advisor than 4chin
View source ↗ - Newszacks.com·45d ago·Neutral
Here's Why Encompass Health Can Be a Smart Addition to Your Portfolio EHC's rising demand, higher patient acuity and hospital expansion support growth, while rising expenses and debt remain key risks.
View source ↗ - Newszacks.com·47d ago·Positive
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - News (Marketaux)finance.yahoo.com·50d ago·Positive
Encompass Health's CFO Trimmed His Stake as Shares Jumped After Earnings. Here's What to Know Coltharp, EVP and chief financial office[+226 characters]
View source ↗ - News (RSS)fool·50d ago·Negative
Encompass Health's CFO Trimmed His Stake as Shares Jumped After Earnings. Here's What to Know This sale reduced an insider's direct common stock position by 27%, though a majority of the position remains held through trusts and spousal holdings.
View source ↗ - News (RSS)fool·50d ago·Neutral
Should You Worry That Encompass Health's CEO Sold Into a Rally? Here's What to Know Tarr reduced his direct equity stake but retains roughly 268,000 shares valued at $33.7 million.
View source ↗ - Newsfool.com·50d ago·Negative
What Three Encompass Health Insiders Selling Signals After a Rate Increase The transaction realized approximately $1.1 million at a weighted average price of $125.95 per share. The executive reduced his direct common stock holdings by 11% through this open-market sale.
View source ↗ - Newsfool.com·50d ago·Negative
Encompass Health's CFO Trimmed His Stake as Shares Jumped After Earnings. Here's What to Know Coltharp executed the sale of 18,869 shares at a weighted average price of $125.38 per share on August 10. The transaction reduced the executive's direct equity position by 27%, while his total beneficial ownership decreased by 7%.
View source ↗ - Newsfool.com·50d ago·Positive
Should You Worry That Encompass Health's CEO Sold Into a Rally? Here's What to Know The transaction involved 173,148 shares sold at a weighted average price of $125.47, totaling approximately $21.7 million. This disposition represents 39% of the CEO's direct common stock holdings in the company.
View source ↗ - News (RSS)investing.com·55d ago·Neutral
Encompass Health Named Top SMidCap Pick by TD Cowen
View source ↗ - Newsprnewswire.com·56d ago·Neutral
Encompass Health prices private offering of additional 5.875% senior notes due 2034 BIRMINGHAM, Ala., Aug. 10, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the pricing of a private offering of an additional $100 million in aggregate principal amount of its 5.875% senior notes due 2034 (the "Additional Notes") at a price of 98.75% of the principal amount thereof.
View source ↗ - News (RSS)seekingalpha·56d ago·Neutral
Encompass Health announces private offering of 5.875% senior notes
View source ↗ - Newsprnewswire.com·57d ago·Neutral
Encompass Health announces launch of private offering of 5.875% senior notes due 2034 BIRMINGHAM, Ala., Aug. 10, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it has commenced a private offering of an additional $100 million in aggregate principal amount of 5.875% senior notes maturing in 2034 (the "Additional Notes"), subject to market and other conditions.
View source ↗ - Newsmarketbeat.com·59d ago·Neutral
Encompass Health Q2 Earnings Call Highlights Encompass Health NYSE: EHC reported second-quarter 2026 results marked by revenue, earnings and discharge growth, prompting the inpatient rehabilitation provider to raise its full-year outlook.
View source ↗
Earnings
Wed, Oct 28(in 3 weeks)
Consensus estimate $1.36 per share
Typical surprise +11.4% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 5$1.55 vs $1.48beat
- Thu, Apr 30$1.60 vs $1.51beat
- Thu, Feb 5$1.46 vs $1.29beat
- Wed, Oct 29$1.23 vs $1.19beat
- Tue, Aug 5$1.40 vs $1.23beat
- Thu, Apr 24$1.37 vs $1.19beat
Estimates and results for EHC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by EHC officers and directors.
- Bought
- —
- Sold
- $47.8m
0 trades
18 trades
- Price Andrew Lsold
- Darby John Patricksold
- Coltharp Douglas Esold
- Tarr Mark Jsold
- Tarr Mark Jsold
- Darby John Patricksold
- Coltharp Douglas Esold
- Coltharp Douglas Esold
82 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (24d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (22d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Apr 7, 2023 (24d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jan 3, 2023 (28d later)Buy$1,001 - $15,000
- Peter Meijerhouse · MI03 · disclosed Mar 16, 2021 (28d later)Sell$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Oct 7, 2020 (41d later)Sell$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Jun 15, 2020 (27d later)Buy$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Aug 29, 2019 (29d later)Sell$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Apr 8, 2019 (24d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.